Episode
Developing an Alternative to Opioids for Post-Surgical Pain
- Podcast
- The Bio Report
- Published
- Dec 24, 2025
- Duration seconds
- 1547
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/developing-an-alternative-to-opioids-for-post-surgical-pain/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-bio-report-1092382/developing-an-alternative-to-opioids-for-post-surgical-pain.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The approach to post-surgical pain relief has relied on short-duration treatments and notably opioids. That’s led to the associated risks of dependence and abuse, prolonged hospitalizations, and slower recoveries. Allay Therapeutics is developing an alternative to opioids to treat post-surgical pain with an initial focus on knee replacement surgeries. Allay’s guitar pick-sized polymer is implanted during surgical procedures and it releases the analgesic bupivacaine as it dissolves over 30 days. We spoke to Adam Gridley, CEO of Allay Therapeutics, about post-surgical pain, the need for alternatives to opioids; and the company’s implanted, extended-release analgesic.